Nasdaq-listed LivaNova, a London-headquartered medical technology company, has priced a US$300m of convertible senior 144a notes due March 15, 2029, with a coupon of 2.5% There is an additional US$45m…
London: LivaNova prices US$300m five-year 144a convertible notes
…
…






